| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872901 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
Maximum intravenous doses of N-acetylcystein reduce the incidence of acute kidney injury in patients with kidney disease undergoing coronary artery bypass graft surgery, abolish oxidative stress, and mitigate the negative effect of CPB on renal function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eduesley RN, Luis Henrique W. MD, PhD, Fabio A. MD, PhD, Luiz B. MD, PhD, Ludhmila A. MD, PhD, Suely P. RN, Luciano F. MD, PhD, Maria Heloisa M. PhD, Luiz A. MD, PhD, Jose J.G. MD, PhD,